[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
May 20, 1998

Insulin Treatment for Type 2 Diabetes

Author Affiliations

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;279(19):1523-1526. doi:10-1001/pubs.JAMA-ISSN-0098-7484-279-19-jbk0520

To the Editor.—Dr Hayward and colleagues1 emphasize that therapy in type 2 diabetes, especially insulin therapy, was rarely effective in actual clinical practice in achieving tight glycemic control. Few patients receiving insulin therapy reached commonly proposed goals for near normalization of HbA1c levels. While overall, 60% had HbA1c levels of at least 8% (0.08), only 43% of the 690 patients treated with sulfonylureas and 18% of the 184 patients not receiving any hypoglycemic medication in this health maintenance organization had HbA1c levels of at least 8% (0.08).